Patient Safety

The Government’s announcement today increasing availability of the COVID-19 antiviral medication, Paxlovid, is both positive and concerning for the country’s largest membership body of GPs

A Medsafe investigation has confirmed no contaminated Lucas’ Papaw Ointment made it into New Zealand, despite a company importing it from Australia outside normal distribution channels

Medsafe is investigating whether any batches of the popular skin product Lucas’ Pawpaw Ointment that were recalled in Australia due to microbial contamination have been sold in New Zealand

University of Auckland researchers are warning pregnant women to be careful when taking fish oil supplements, due to new research finding highly oxidised fish oils are harmful to pregnant rats

Sunscreen manufacturers have 18 months to comply with new quality standards, or risk facing fines of up to $600,000 

The New Zealand Medical Association has made a formal submission objecting to a proposed expansion of medicines pharmacist prescribers can prescribe.

Two bids to widen access to higherstrength doses of ibuprofen have been declined by the Medicines Classification Committee.

The New Zealand Medical Association is opposing a proposed expansion of the number of medicines pharmacist prescribers can prescribe

A common painkiller is sending a steady stream of New Zealand children to the liver transplant waiting list and now a new study is hoped to stem the tide

When the Government’s COVID-19 alert level system was announced in March 2020, the team at Te Puna Ora o Mataatua Charitable Trust (TPO) leapt into action